|
Biotech Business
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 410 articles |
 Page 2 of 6 
|
FDA ACCEPTS AZX100 IND FOR DERMAL/HYPERTROPHIC SCARRING.(Clinical repo...
March 01, 2008
ADOLOR SUBMITS ADL5747 IND FOR DELTA OPIOID RECEPTOR TARGET.
February 01, 2008
FDA GIVES TENTATIVE APPROVAL OF STAVZOR.
February 01, 2008
NEW DRUG FIGHTS BACTERIAL INFECTIONS IN NOVEL WAY.
February 01, 2008
POSITIVE PRECLINICAL RESULTS FROM TOPICAL ZYBRESTAT.
February 01, 2008
MILLIPORE/ABEOME TO DISTRIBUTE STEM CELL ANTIBODY.(Company overview)
January 01, 2008
NYMOX REPORTS POSITIVE RESULTS FOR 2 YEAR NX-1207 BPH STUDY.(Clinical ...
January 01, 2008
BREAKTHROUGH FOR CANCER PAIN.
January 01, 2008
OSTEOPOROSIS: AN EQUAL OPORTUNITY ILLNESS.
January 01, 2008
UCB FILES NDA FOR LACOSAMIDE FOR DIABETIC NEUROPATHIC PAIN.
January 01, 2008
NOVABAY REPORTS POSITIVE PHASE I AGANOCIDE RESULTS FOR MRSA.
January 01, 2008
U.S. AWARDS $15 MIL TO GEOVAX HIV/AIDS VACCINE PROGRAM.
November 01, 2007
BIOGEN IDEC/JOHNS HOPKINS TO DEVELOP NEURODEGENERATIVE THERAPIES.
November 01, 2007
AETHLON ANNOUNCES BIRD FLU RESEARCH COLLABORATIONS.
November 01, 2007
NIH AWARDS PHARMATHENE UP TO $13.9 MIL FOR ANTHRAX ANTI-TOXIN.
November 01, 2007
ADVANCED LIFE SCIENCES TO STUDY CETHROMYCIN FOR ANTHRAX.
October 01, 2007
GENTA STARTS PHASE 3 AGENDA TRIAL OF GENASENSE FOR MELANOMA.
October 01, 2007
QUATRX ENROLLS OPHENA PHASE 3 FOR POSTMENOPAUSAL SYNDROME.
October 01, 2007
ENCOURAGING PHASE II DATA ON GENVEC HIV VACCINE.
October 01, 2007
ANTISENSE AGENT PROMISING TREATMENT FOR HEART DISEASE.
September 01, 2007
TARGACEPT INITIATES PHASE I CLINICAL TRIAL OF TC-5619.
September 01, 2007
SEVERE TRAUMA AFFECTS CHILD'S BRAIN FUNCTION.
September 01, 2007
OREXIGEN PRESENTS CONTRAVE CLINICAL REVIEW AT CBI.
September 01, 2007
MIT MODEL COULD PREDICT CELL'S RESPONSE TO DRUGS.
September 01, 2007
CYTRX CLINICAL TRIAL OF ARIMOCLOMOL FOR ALS SHOWS PROMISE.
August 01, 2007
GLAXOSMITHKLINE FILES ROTARIX APPLICATION FOR FDA APPROVAL.
August 01, 2007
EXUBERA SHOWED PULMONARY SAFETY WITH BLOOD SUGAR CONTROL.
August 01, 2007
ATHELON HEMOPURIFIER REMOVES MORE THAN 99% OF DENGUE VIRUS.
July 01, 2007
NEURONASCENT LICENSES ANIMAL CELLS TO LIFELINE CELL TECHNOLGY.
July 01, 2007
CELLDEX THERAPEUTICS INITIATES PHASE 2/3 TRIAL OF CDX110.
July 01, 2007
AFFYMETRIX COMPLETES LARGEST GENECHIP PLANT MICROARRAY STUDY.
July 01, 2007
FDA APPROVES XYZAL TABLETS FOR THE RELIEF OF ALLERGIES/HIVES.
July 01, 2007
HEMISPHERX/ARMADA TO LAUNCH ALFERON N INJECTION.
June 01, 2007
ARTHROCARE GETS FDA CLEARANCE FOR ALL-PEEK IMPLANT SYSTEM.
June 01, 2007
AVICENA FILES COMPOSITION OF MATTER PATENT APPLICATION.
June 01, 2007
BAXTER UNVEILS HYLENEX FOR OPHTHALMIC SURGERY.
June 01, 2007
ROYALTY PHARMA/INNEXUS SIGN PACT FOR DXL ANTIBODY.
June 01, 2007
NOVOZYMES OPENS IOWA CENTER FOR ETHANOL/BIOFEUL RESEARCH.
May 01, 2007
ANTIOXIDANT MOLECULE MINIMIZES STROKE-LINKED BRAIN DAMAGE.
May 01, 2007
MEDIMMUNE STARTS PHASE I TRIAL FOR PSORIASIS TREATMENT.
May 01, 2007
BIDIL HAS SHOWN REDUCTIONS IN DEATH OF BLACK HEART PATIENTS.
May 01, 2007
AVASTIN PLUS CHEMOTHERAPY PHASE III SHOWS IMPROVED PFS.
April 01, 2007
SIGNIFICANT PHASE III CIMZIA RESULTS IN RHEUMATOID ARTHRITIS.(Clinical...
April 01, 2007
GILEAD COMPLETES PHASE II OF HIV INTEGRASE INHIBITOR GS 9137.(Clinical...
April 01, 2007
FDA GRANTS ORPHAN DRUG DESIGNATION FOR DROXIDOPA.
March 01, 2007
HESCGRO MEDIUM ADVANCES HUMAN EMBRYONIC STEM CELL RESEARCH.
March 01, 2007
SAMARITAN'S SP-10 HAS GOOD ANTIVIARL ACTIVITY WITH HCV.
March 01, 2007
OSCIENT COMPLETES ENROLLMENT IN PHASE IV OF FACTIVE TABLETS.
March 01, 2007
NEURORECOVERY GETS ORPHAN DRUG DESIGNATION.
February 01, 2007
MEDICINOVA INITIATES PHASE II TRIAL FOR MN-221.
February 01, 2007
OXIGENE GETS POSITIVE RESULTS OF PHASE II STUDY OF CA4P.
February 01, 2007
BRONCHIAL THERMOPLASTY ONE "TOP 10 INNOVATIONS" OF 2007.
February 01, 2007
AVAA WORLD HEALTH LAUNCHES CLINICAL TRIAL FOR NEUROSKIN.
February 01, 2007
NVENTA UPDATES DEVELOPMENT STRATEGY ON HSPE7.
January 01, 2007
MEMORY PHARMACEUTICALS COMPLETES ENROLLMENT FOR MEM 1003.(Clinical rep...
January 01, 2007
ANESIVA FILES NDA FOR ZINGO TO REDUCE PAIN FROM NEEDLES.
January 01, 2007
QUESTCOR INITIATES QSC-001 CLINICAL PROGRAM.
January 01, 2007
$5 BILLION KNEE IMPLANT MARKET GETS BOOST FROM WOMEN.
January 01, 2007
SYNVISC IMPROVES OSTEOARTHRITIS PAIN.
January 01, 2007
INNOVIVE ENROLLS FOR PHASE I OF INNO-305 PEPTIDE IMMUNOTHERAPY.
December 01, 2006
IDM PHARMA SUBMITS NDA FOR JUNOVAN OSTEOSARCOMA TREATMENT.
December 01, 2006
INFLAMMATORY ENZYNE LP-PLA2 PREDICTS RECURRENT STROKE.
December 01, 2006
CELLDEX/LUDWIG INST. FORM RESEARCH COLLABORATION.
December 01, 2006
COLAZAL "FOOD EFFECT" APPLICATIOM GRANTED FDA APPROVAL.
November 01, 2006
VIOQUEST DOSES FIRST PATIENT IN PHASE I/IIA VQD-001 TRIAL.
November 01, 2006
CALGENEX UNVEILS OMEGANOL FOR CHOLESTEROL/TRIGLYCERIDES.
November 01, 2006
ALEXION ENROLLS ECULIZUMAB PHASE III SHEPHERD TRIAL.
November 01, 2006
CYTOGEN LAUNCHES SOLTAMOX ORAL LIQUID FOR BREAST CANCER.
October 01, 2006
WYETH/PROGENICS START PHASE 2 TRIAL OF ORAL METHYLNALREXONE.
October 01, 2006
KOSAN NAMES ITS LEAD HSP90 INHIBITOR COMPOUNDS.
October 01, 2006
GENVAC VACCINE ENTERS HIV HUMAN THERAPEUTIC CLINICAL TRIALS.
October 01, 2006
BIRCH BARK COMPOUND MAY BE POTENT PROSTATE CANCER FIGHTER.
September 01, 2006
ACCENTIA TO LICENSE ALL MAYO ANTIFUNGALS FOR CHRONIC SINUSITIS.
September 01, 2006
AVI BIOPHARMA MODIFIES HEPATITIS C VIRUS CLINICAL STUDY.
September 01, 2006
ILYPSA COMPLETES PHASE 1 CLINICAL TRIAL OF ILY101.
June 01, 2006
|
